Skip to search formSkip to main contentSkip to account menu

Revasc

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

desirudin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines
Introduction and aims Patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) are often managed conservatively… 
2018
2018
Efficacy Outcomes of Endovascular Versus Surgical Revascularization in Critical Limb Ischemia: Results From a Prospective Cohort Study
Data on efficacy outcomes of endovascular versus surgical revascularization in patients with critical limb ischemia (CLI) in… 
2017
2017
Technique of delayed endovascular hemostatic closure for large bore vascular access site: A case series.
2016
2016
Safety of hydrophilic guidewires used for side-branch protection during stenting and proximal optimization technique in coronary bifurcation lesions.
2012
2012
Double-blinded, placebo-controlled, randomized gene therapy using surgery for vector delivery.
2005
2005
Long-Term Benefits and Limitations of Combined Antianginal Drug Therapy in Elderly Patients with Symptomatic Chronic Coronary Artery Disease
Background: Chronic angina is a common and disabling disorder in the elderly. Combined antianginal drug treatment represents the… 
1999
1999
Cost-effectiveness of desirudin in the prevention of the thromboembolic complications of surgery
SummaryNew therapies reduce the risk of deep-vein thrombosis (DVT) following orthopaedic surgery, but may be more costly than low… 
1997
1997
Effect of a 15-Minute Infusion of DDAVP on the Pharmacokinetics and Pharmacodynamics of ™REVASC during a Four-Hour Intravenous Infusion in Healthy Male Volunteers
Summary Plasma pharmacokinetics, effect on coagulation parameters, and safety and tolerability of an intravenous infusion of… 
1996
1996
Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis
1 We compared the direct thrombin inhibitor, desulfatohirudin (REVASC) and the indirect thrombin inhibitor, heparin, as adjuncts… 
Review
1994
Review
1994
Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).
BACKGROUND As a result of their polypeptidic nature, hirudins could theoretically elicit an immunologic response in humans… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)